myoscience
iovera Treatment for Dynamic Wrinkles Now Offered by Drs. Jean & Alastair Carruthers and Doctor Shannon Humphrey
myoscience 17.09.2013 15:00 --------------------------------------------------------------------------- REDWOOD CITY, Calif., 2013-09-17 15:00 CEST (GLOBE NEWSWIRE) -- myoscience is pleased to announce that the iovera* treatment is now available from the Vancouver Cosmetic Medicine and Dermatology Clinic, Doctors Alastair and Jean Carruthers and Doctor Shannon Humphrey. 'We are so pleased to work with leading physicians who have numerous published papers on the seminal work done with neurotoxins,' says Clint Carnell, CEO of myoscience. 'The Carruthers were instrumental in the development of neurotoxins for cosmetic use and now they have chosen to help bring iovera* to market in Canada and the rest of the world.' The iovera* treatment is a toxin-free alternative for patients that want to improve their appearance and desire immediate results with nothing left behind in their body. iovera* utilizes Focused Cold Therapy(TM) , a true platform technology, to stimulate the body's natural response to cold, temporarily relaxing the muscles that cause wrinkles and block pain signals. The treatment for dynamic wrinkles has been available in the European Union since March of 2013. Doctor Jean Carruthers feels iovera? will be an important new tool for doctors that want to offer patients options, 'We are all familiar with the safety and efficacy of cosmetic neuromodulation using neurotoxins. The iovera? technology is a totally new approach to reducing wrinkles by treating nerves with cold. After some months, the nerves recover and retreatment may be desired.' Doctor Shannon Humphrey is enthusiastic to be one of the first to offer the iovera? treatment, 'iovera provides us with a new alternative to treat forehead wrinkles in a natural way that provides immediate results, something we feel many patients will find appealing.' About myoscience Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold Therapy(TM), the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions. The myoscience technology has also been cleared in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com. About Vancouver Cosmetic Medicine Doctors Alastair and Jean Carruthers and Doctor Shannon Humphrey are prominent Vancouver physicians specializing in cosmetic medicine; specifically minimally invasive treatments to help our patients look and feel their best. Our practice includes the use of popular cosmetic treatments including Botox Cosmetic(r), Xeomin Cosmetic(r), Dysport Cosmetic(r), tissue fillers, laser and energy-based treatments, and optimized skincare. Dr. Jean and Alastair Carruthers and Dr. Shannon Humphrey are committed to advancing the science of cosmetic medicine. They operate a busy clinical research unit, publish their research regularly in medical journals and lecture to the medical community in Canada and worldwide. The combination of research advancement, clinical teaching and leadership and clinical expertise has helped hundreds of men & women attain successful results. www.carruthers-humphrey.com The myoscience logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13581 CONTACT: Alexandra Mack 650-421-0609 amack@myoscience.com News Source: NASDAQ OMX 17.09.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: myoscience United States Phone: Fax: E-mail: Internet: ISIN: US9902131674 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden